Search research articles
Contact Us
Filters
Showing results (41-50 of 223) with videos related to
Page
of 23
Sort By:
Clinical Therapeutics
|
November 1, 1993
Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research
C M Kozma, C E Reeder, R M Schulz
Medical Care
|
August 1, 1984
The effect of a Medicaid drug copayment program on the utilization and cost of prescription services
A A Nelson, C E Reeder, W M Dickson
Cytometry
|
July 1, 1989
Technique for cellular fluorescence distribution analysis
R D Robinson, J E Reeder, L L Wheeless
Medical Care
|
October 1, 1990
Expanding Medicaid drug formulary coverage. Effects on utilization of related services
C M Kozma, C E Reeder, E W Lingle
Urology
|
January 28, 2015
Reply: To PMID 25623666
Timothy K Byler, Jay E Reeder, Imad Nsouli, et al.
Pharmacoepidemiology and Drug Safety
|
April 15, 2022
Applying mixture cure survival modeling to medication persistence analysis
Chao Cai, Bryan L Love, Ismaeel Yunusa, et al.
JCO Clinical Cancer Informatics
|
October 8, 2025
Challenges and Opportunities in Optimizing Social Risk and Need Screening for 21st Century Cancer Care
Katherine E Reeder-Hayes, Emily M Ray, Jennifer Elston Lafata
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2020
Leveraging existing data to contextualize phase II clinical trial findings in oncology
E M Ray, L A Carey, K E Reeder-Hayes
Journal of Medicinal Chemistry
|
October 1, 1977
2-(2-Aminoethylamino)-1,2-diphenylethanol derivatives, a new class of topical antiinflammatory agents
R I Fryer, A Boris, J V Earley, et al.
Cancer
|
January 28, 2021
Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer
Katherine E Reeder-Hayes, Sophie E Mayer, Jennifer L Lund
Page
of 23
Search research articles
Search
Showing results (41-50 of 223) with videos related to
Sort By:
Page
of 23
Clinical Therapeutics
|
November 1, 1993
Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research
C M Kozma, C E Reeder, R M Schulz
Medical Care
|
August 1, 1984
The effect of a Medicaid drug copayment program on the utilization and cost of prescription services
A A Nelson, C E Reeder, W M Dickson
Cytometry
|
July 1, 1989
Technique for cellular fluorescence distribution analysis
R D Robinson, J E Reeder, L L Wheeless
Medical Care
|
October 1, 1990
Expanding Medicaid drug formulary coverage. Effects on utilization of related services
C M Kozma, C E Reeder, E W Lingle
Urology
|
January 28, 2015
Reply: To PMID 25623666
Timothy K Byler, Jay E Reeder, Imad Nsouli, et al.
Pharmacoepidemiology and Drug Safety
|
April 15, 2022
Applying mixture cure survival modeling to medication persistence analysis
Chao Cai, Bryan L Love, Ismaeel Yunusa, et al.
JCO Clinical Cancer Informatics
|
October 8, 2025
Challenges and Opportunities in Optimizing Social Risk and Need Screening for 21st Century Cancer Care
Katherine E Reeder-Hayes, Emily M Ray, Jennifer Elston Lafata
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2020
Leveraging existing data to contextualize phase II clinical trial findings in oncology
E M Ray, L A Carey, K E Reeder-Hayes
Journal of Medicinal Chemistry
|
October 1, 1977
2-(2-Aminoethylamino)-1,2-diphenylethanol derivatives, a new class of topical antiinflammatory agents
R I Fryer, A Boris, J V Earley, et al.
Cancer
|
January 28, 2021
Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer
Katherine E Reeder-Hayes, Sophie E Mayer, Jennifer L Lund
Page
of 23